Re: Pharmacogenetic Testing Options Relevant to Psychiatry in Canada
- PMID: 32400175
- PMCID: PMC7492891
- DOI: 10.1177/0706743720925735
Re: Pharmacogenetic Testing Options Relevant to Psychiatry in Canada
Keywords: medication decision support; pharmacogenetics; testing.
Comment in
-
Reply to Dawes et al.Can J Psychiatry. 2020 Aug;65(8):586-587. doi: 10.1177/0706743720925736. Epub 2020 May 19. Can J Psychiatry. 2020. PMID: 32425056 Free PMC article. No abstract available.
Comment on
-
Pharmacogenetic Testing Options Relevant to Psychiatry in Canada: Options de tests pharmacogénétiques pertinents en psychiatrie au Canada.Can J Psychiatry. 2020 Aug;65(8):521-530. doi: 10.1177/0706743720904820. Epub 2020 Feb 17. Can J Psychiatry. 2020. PMID: 32064906 Free PMC article. Review.
References
-
- Swen J, Nijenhuis M, Rhenen M, et al. Pharmacogenetic information in clinical guidelines: The european perspective. Clin Pharm Therap. 2018;103(5):795–801. - PubMed
-
- El Morabet N, Uitvlugt EB, van den Bemt B, van den Bemt P, Janssen M, Karapinar Carkit F. Prevalence and preventability of drug-related hospital readmissions: a systematic review. J Am Geriatr Soc. 2018;66(3):602-608. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
